
EQRx Investor Relations Material
Latest events

Q1 2023
EQRx
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from EQRx Inc
Access all reports
EQRx, Inc. is a biotechnology company focused on developing and delivering innovative medicines at more affordable prices. The company aims to address the high cost of drugs by re-engineering the drug discovery and development process, creating therapies for conditions such as cancer and immune-inflammatory diseases. EQRx seeks to offer high-quality treatments that are more accessible to healthcare systems and patients. The company collaborates with global partners to advance its drug pipeline while leveraging advanced technologies to expedite drug development and reduce costs. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
EQRX
Country
🇺🇸 United States